• Latest
    • Big pharma
    • Biotechnology
    • CRISPR
    • Generics
    • Unified Patent Court
  • Regions
    • Americas
    • Europe
    • Asia
    • Asia-Pacific
  • Careers
  • Events
    • Conferences
    • Conference Videos
    • Webinars
  • Directory
  • Magazines
  • About
  • Contact
  • Newsletter
  • Login
  • Subscribe
  • Home
  • About
  • Contact
  • Newsletter
  • Login


Subscribe
  • Home
  • Search Results

Search Results

Reset all filters
Channel
Geography
Company
Refine Search

News & Features

Commercialising genomic tech in Nigeria
Africa
Commercialising genomic tech in Nigeria
Genomic innovations involve vast amounts of research, making patents, copyrights, and trade secrets vital, explains Olusola Tunmise-Ajani of Inventa International.   29 April 2025
How post-filing data rescued Novo Nordisk’s Ozempic patent in China
Asia
How post-filing data rescued Novo Nordisk’s Ozempic patent in China
The Beijing IP court’s decision to revive a key semaglutide patent based on experimental data has far-reaching legal and economic implications, says Jennifer Che of Eagle IP   15 October 2024
How to navigate patent term adjustment in China
Asia
How to navigate patent term adjustment in China
Recent updates to China’s patent law provide guidelines on PTA calculations, definitions of delays and challenging decisions, say Audrey Cheung, Yolanda Wang and Jennifer Che of Eagle IP.   8 October 2024
Americas
‘Masking only works for so long’: Working with ADHD
Being a lawyer with ADHD is far from easy due to widespread misconceptions about the condition but there are ways to offer support, says Lisa Mueller of Casimir Jones.   1 August 2024
Big Pharma
Amgen v Sanofi/Regeneron in Japan: Function, sequence, mechanism
Amgen patents declared valid in Germany and Japan have also been deemed invalid by the European Patent Office, US Supreme Court, and in a separate Japan decision: but why? Takanori Abe of Abe & Partners examines the details.   19 March 2024
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
Wilson Sonsini, Desmarais, and Wolf Greenfield were among the winners at the inaugural LSPN Awards USA 2025 in Boston, which celebrated excellence in life sciences IP across 20 categories.   8 May 2025
Europe
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
Industry body says agreement doesn’t address ‘longstanding industry concerns’ about IP | Deal criticised for ‘lack of detail’ on IP, particularly for UK life sciences and general legal sector | £25.5bn deal offers provisions for medical devices | Smith+Nephew hopes deal will help build trade for healthcare.   8 May 2025
Americas
LSPN: Counsel grapple with AI’s impact on training and critical thinking
Legal heads from Pfizer and The Broad Institute stress the need for cross-disciplinary teams and careful training as AI software becomes mainstream, reports Marisa Woutersen from LSPN 2025.   8 May 2025
Europe
'Nothing can stand in the way of our work': Ukraine resumes IP system
As Ukraine lifts the wartime pause on IP deadlines, the country's lawyers are determined to get back to business as usual—in spite of the ongoing missile attacks and power outages, finds Sarah Speight.   7 May 2025
Americas
LSPN: Trump's policy storm causing chaos and confusion
In just 100 days, the Trump administration has issued a record-breaking 90 executive orders—triggering operational uncertainty, staffing upheaval, and growing delays at the US Patent and Trademark Office, hears Marisa Woutersen at LSPN in Boston.   7 May 2025
Load More

Companies

company
Appleyard Lees European Patent & Trade Mark Attorneys
company
Kaye Scholer
company
Dechert LLP
company
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo
company
Powell Gilbert LLP
company
WilmerHale
company
O’Melveny & Myers LLP
company
Kilpatrick Townsend
company
Nutter McClennen & Fish
  • Home
  • News
  • About us
  • Contact
  • Terms of Use
  • Privacy Policy
  • Terms of Subscription

LSIPR
Newton Media Ltd
Kingfisher House
21-23 Elmfield Road
BR1 1LT
United Kingdom

  • Twitter
  • Linkedin